gene

PGC1A

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PGC1A: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

202Connections
0Hypotheses
2Analyses
50Outgoing
50Incoming
0Experiments
2Debates

Summary

PGC1A is a gene implicated in neurodegeneration research. Key relationships include: activates, interacts with, implicated in. Associated with Aging, Als, Alzheimer. Connected to 88 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

🧬 Gene Info
Gene SymbolPGC1A
Full NamePPARG Coactivator 1 Alpha
Chromosome4p15.1
Target ClassProtein
Functionis an important component in the neurobiology of neurodegenerative diseases.
Mechanism of ActionPrioritized from 1 SciDEX hypotheses, including: Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Circuits
Primary Expressionneurons, astrocytes, and oligodendrocytes [18] - Regulation: Highly responsive to environmental and h
DruggabilityUndruggable (0.23)
Molecular Weight91 kDa
PathwaysAMPK, MAPK pathway
UniProt IDQ9UBX3
NCBI Gene ID10887
Ensembl IDENSG00000100739
GeneCardsPGC1A
Human Protein AtlasPGC1A
Associated DiseasesAging, Als, Breast Cancer, Cancer, Huntington's disease, neurodegeneration
InteractionsACETYL-COA, AGING, AMPK, AND, APOE, ATP
SciDEX TargetView Target Profile
KG Connections202 knowledge graph edges
DatabasesGeneCardsHPASTRING
🔮 Predicted Structure: PGC1A — AlphaFold Q9UBX3 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (2)

Knowledge base pages for this entity

Canonical Page

PGC1A Gene

gene · 1324 words

PGC1A Protein

protein · 727 words

Pathway Diagram

graph TD
    PGC1A["PGC1A"]
    PGC1A -->|"activates"| NRF1["NRF1"]
    PGC1A -->|"activates"| NRF2["NRF2"]
    PGC1A -->|"regulates"| MITOCHONDRIAL_BIOGENESIS["MITOCHONDRIAL_BIOGENESIS"]
    PGC1A -->|"regulates"| MITOCHONDRIAL_ACTIVITY["MITOCHONDRIAL_ACTIVITY"]
    PGC1A -->|"activates"| OXIDATIVE_PHOSPHORYLATION["OXIDATIVE_PHOSPHORYLATION"]
    PGC1A -->|"activates"| METASTASIS["METASTASIS"]
    PGC1A -->|"activates"| Diabetes["Diabetes"]
    PGC1A -->|"activates"| Cardiac["Cardiac"]
    PGC1A -->|"activates"| Heart_Failure["Heart Failure"]
    PPARGC1A["PPARGC1A"] -->|"encodes"| PGC1A
    AMPK["AMPK"] -->|"phosphorylates"| PGC1A
    LC3B["LC3B"] -->|"activates"| PGC1A
    PER["PER"] -->|"expressed in"| PGC1A
    FASN["FASN"] -->|"activates"| PGC1A
    NFKBIA["NFKBIA"] -->|"activates"| PGC1A
    AGING["AGING"] -->|"interacts"| PGC1A
    NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"interacts"| PGC1A

Outgoing (142)

TargetRelationTypeStr
mitochondrial biogenesispromotesprocess0.95
Mitochondrial Biogenesisregulatesprocess0.95
Inflammatory Cytokinesregulatescompound0.90
Amyloid-Betadownregulatesprotein0.90
PARVALBUMIN INTERNEURONSregulatesentity0.90

Incoming (60)

SourceRelationTypeStr
PPARGC1Aencodesgene0.95
SIRT1activatesgene0.90
PPARGinteracts_withentity0.90
AMPKphosphorylatesprotein0.90
h-827a821btargets_genehypothesis0.90

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (2)

Scientific analyses that reference this entity

Epigenetic reprogramming in aging neurons

neurodegeneration | 2026-04-04 | 9 hypotheses Top: 0.914

CRISPR-based therapeutic approaches for neurodegenerative diseases

neurodegeneration | 2026-04-03 | 14 hypotheses Top: 0.803

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (2)

Multi-agent debates referencing this entity

Epigenetic reprogramming in aging neurons

closed · Rounds: 4 · Score: 0.95 · 2026-04-10

Evaluate the potential of CRISPR/Cas9 and related gene editing technologies for

closed · Rounds: 4 · Score: 0.95 · 2026-04-03